POPULARITY
Does cataract surgery increase your risk of developing macular degeneration? Learn more during a conversation with guest expert Emily Y. Chew, MD, who will discuss this question and the relationship between cataracts and macular degeneration.
Emily Y. Chew, MD Director, Division of Epidemiology and Clinical Applications Medical Officer National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD
The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).
The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).
Interview with Emily Y. Chew, MD, author of Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39
Interview with Emily Y. Chew, MD, author of Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39
The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).
The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).
The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).
Interview with Emily Y. Chew, MD, author of Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4
Interview with Emily Y. Chew, MD, author of Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
Guest: Emily Y. Chew, M.D. Deputy Director, Division of Epidemiology and Clinical Research National Eye Institute (NEI) Bethesda, MD